Table 5.
Distribution of postoperative complications by the breast implants on subgroup analysis (n = 124).
| Values | |||||
|---|---|---|---|---|---|
| Sebbin® Sublimity (n = 16) |
BellaGel® SmoothFine (n = 68) |
Motiva ErgonomixTM (n = 28) |
Mentor® MemoryGel™ Xtra (n = 8) |
BellaGel® Smooth (n = 4) |
|
| Total incidences | 6 (4.84%) | 11 (8.87%) | 0 (0.00%) | 0 (0.00%) | 2 (1.61%) |
| Early hematoma | 1 (0.81%) | 1 (0.81%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Early seroma | 1 (0.81%) | 3 (2.42%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Rupture | 1 (0.81%) | 2 (1.61%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Capsular contracture | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Rippling | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1 (0.81%) |
| Shape deformation | 2 (1.61%) | 3 (2.42%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
| Infection | 1 (0.81%) | 2 (1.61%) | 0 (0.00%) | 0 (0.00%) | 1 (0.81%) |
| Stretch deformities with skin excess | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) |
Values are the number of cases with percentage for the total sample.